RYSORI
Live / Allowed — Published for opposition (as of 31 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Feb 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99639030
- Mark type
- Stylized text
- Filed
- 06 Feb 2026
- Published for opposition
- 31 Mar 2026
- Attorney of record
- Maryam Arastu
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
Owner
- AbbVie Inc., North Chicago, IL, US
- AbbVie Inc., North Chicago, IL, US
Prosecution history
- 31 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Mar 2026 — ASSIGNED TO EXAMINER
- 06 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 06 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Feb 2026 — NEW APPLICATION ENTERED